Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
The Effect of Type 2 Diabetes on Cognitive Function in Middle-Aged Patients
Religion and Spirituality Not Significantly Associated with Reduced Incidence of T2D
Interventions Utilizing Fitness Trackers Among Adults with Cardiometabolic Conditions
Narrowing the Scope of Antidiabetic Treatment Options Utilizing Patient-Specific Factors
Letter from the Editor
There is no doubt that recording your activity will cause you to try harder. Although I ride the same route with our bike club almost every day, I look to see if I set any new times for the multiple segments we have mapped out.
Most cyclists use an app called Strava, and it is often said, “if it isn’t on Strava, you didn’t do it.”
Fitbits, Apple Watches and multiple other devices are available for our patients with diabetes to help them record — and hopefully increase — their activity. But do these devices actually make a difference? Our intern Emmanuella Louissaint, PharmD candidate, LECOM College of Pharmacy, has looked through various studies to come up with an answer. Be sure to check out her feature and learn what she found out.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
TOP STORIES — Diabetes News and Research
Could midlife cognitive decline be an indicator of increased dementia risk in patients with type 2 diabetes?
Women who attended religious service had a similar incidence of T2D compared to those that did not.
Fitness trackers are affordable and popular, but do they correlate with better physical activity levels in people with diabetes or other with cardiometabolic conditions?
The abundant options for glucose-lowering medications can make an individualized pharmacologic approach to treatment arduous.
Recent studies show a correlation between patients with diabetes and ICU admissions/mechanical ventilation for COVID-19 infections in the United States.
Researchers examined six different subgroups to determine what factors raised or lowered their risk of developing type 2 diabetes.
Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this newsletter:
Dalia Elabed, PharmD Candidate 2022, University of South Florida Taneja College of Pharmacy
Bernice Ford, 2021 PharmD Candidate, Florida Agricultural & Mechanical University, Caollege of Pharmacy and Pharmaceutical Sciences
Kornelia Ilias, Creighton University | School of Pharmacy and Health Professions Doctor of Pharmacy Candidate Class of 2022
Oluwatayo Ishola, PharmD. Candidate, South College, School of Pharmacy
Emmanuella Louissaint, PharmD candidate, LECOM College of Pharamacy
Destiny Reed, PharmD. Candidate, Florida A&M College of Pharmacy and Pharmaceutical Sciences
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
www.diabetesincontrol.com